Few New Mexicans think the state economy is good or excellent, according to results from the Journal Poll released this week. A plurality of New Mexicans rated economic conditions as “fair” at 43%, ...
Elevar presents age-stratified camrelizumab-rivoceranib data from Phase 3 CARES-310 after two FDA rejections, signaling ...